HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver TransplantationQiang Zhao, Xiaoshun He, Jinbo Huang et al.|Clinical Cancer Research|2025Cited by 5
Protective value of ischemia-free liver transplantation on post-transplant acute kidney injuryQiang Zhao, Xiao-Shun He, Jinbo Huang et al.|JHEP Reports|2025Cited by 3
The Interconnection Between the Liver and Other Organs: Insights for Hepatic Long–Term Normothermic Machine PerfusionXiaoshun He, Zhiying Liu, Meiting Qin et al.|Organ medicine.|2024Cited by 2
Supplementary Data1 from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver TransplantationQiang Zhao, Xiaoshun He, Lu‐En Wai et al.|Unknown|2025Cited by 0
Data from HBV-Specific TCR–T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regimen for Recurrent HBV-Related HCC after Liver TransplantationQiang Zhao, Xiaoshun He, Jinbo Huang et al.|Unknown|2025Cited by 0